AIP earnings call summary

Prepared Highlights

• 第三季度总营收 1,740万美元，环比增长5%，同比增长18%，超出指引上限（CFO）
• 年度合同价值加版税（ACV+royalties）达 7,490万美元，同比增长24%，创历史新高，高于指引上限（CEO）
• 剩余履约义务（RPO）为 1.047亿美元，同比增长34%，首次突破1亿美元（CFO）
• 非GAAP毛利率 91%，GAAP毛利率 90%（CFO）
• 非GAAP运营费用 1,950万美元，GAAP运营费用 2,440万美元；G&A费用已连续三年非GAAP基本持平（CFO）
• 非GAAP运营亏损 350万美元，符合指引；GAAP运营亏损 870万美元（CFO）
• 非GAAP净亏损 380万美元，每股亏损 0.09美元；GAAP净亏损 900万美元，每股亏损 0.21美元（CFO）
• 期末现金及投资 5,620万美元，无金融负债（CFO）
• 自由现金流（含资本开支）为 正250万美元，高于指引中值（CFO）
• 过去12个月可变版税同比增长 36%（CFO）
• AI应用占第三季度授权收入 超过一半（CEO）；新增客户包括Altera、AMD（追加许可）、Dream Chip、NanoXplore、2V Systems等（CEO）

Official Guidance

• 2025年第四季度指引：ACV+royalties 7,400万–7,800万美元；营收 1,840万–1,880万美元；非GAAP运营亏损 230万–330万美元；非GAAP自由现金流 20万–320万美元（CFO）
• 2025年全年指引：ACV+royalties年末值 7,400万–7,800万美元（较此前上调100万）；营收 6,880万–6,920万美元（上调100万）；非GAAP运营亏损 1,250万–1,350万美元；非GAAP自由现金流 250万–550万美元（CFO）

Mgmt Quotes

• “我们实现了又一个创纪录的年度合同价值加版税7,490万美元，同比增长24%。” – Charlie Janac (CEO)
• “AI应用占第三季度授权收入的一半以上，反映了从数据中心到智能边缘对Arteris系统IP的日益采用。” – Charlie Janac (CEO)
• “第三季度我们在所有财务指标上达到或超过了指引，表现强劲。” – Nicholas Hawkins (CFO)
• “我们受到第三季度末RPO同比增长34%所体现的强劲交易执行的鼓舞。” – Nicholas Hawkins (CFO)
• “我们通过控制G&A支出来实现运营杠杆，该支出在非GAAP基础上已保持基本持平超过三年。” – Nicholas Hawkins

Q&A Batch (1-4 of 4)

Q1 — Kevin Garrigan

• Topic: Altera partnership expansion & AMD engagement; reliability as competitive moat
• Key points:
  • Altera uses its own interconnect in FPGA matrix, but Arteris is used in the SoC part; more future opportunities exist.
  • AMD’s Q2 deal was with its central engineering group; Q3 deal was with another group; additional AMD groups remain untapped.
  • Arteris’ installed base has shipped ~3.9 billion SoCs, all functional; reliability is critical because any system IP issue can cause tape-out delays or field failures.
• Mgmt stance: Bullish on Altera/AMD expansion; proud of silicon-proven track record as a competitive advantage.

Q2 — Kevin Cassidy

• Topic: UALink consortium timeline and AMD/Xilinx cross-sell
• Key points:
  • UALink consortium aims to scale data center solutions; Arteris is developing tech to support the consortium’s protocol and already involved in some designs.
  • Xilinx (now part of AMD) was a long-time Arteris customer before the AMD acquisition.
• Mgmt stance: Neutral on UALink specifics (no license timing given); confident in existing AMD/Xilinx relationship.

Q3 — Auguste Richard

• Topic: Royalty inflection timeline; top-tech customer penetration; Q3 bookings estimate
• Key points:
  • Royalty growth lags design starts by 3–6 years; variable royalties trailing 12M to Sept 2025 were up 36% YoY (vs. Sept 2024), roughly 2x license growth.
  • In 2020, HiSilicon made up 90% of variable royalties; now 5 majors + 50 smaller players produce a higher total royalty stream than HiSilicon ever did.
  • TAM is ~$1.0–1.2B; Arteris revenue is ~$68M this year. Over 50% of the “top 40” largest tech companies are customers, but not all are large yet.
  • Bookings estimated in the “~$32M” zip code for Q3; management declined to confirm to avoid setting a disclosure precedent.
• Mgmt stance: Bullish on royalty acceleration (inflection expected by 2028); neutral on bookings disclosure.

Q4 — Joshua Buchalter

• Topic: AI/data center vs. edge mix; FlexGen royalty impact
• Key points:
  • AI currently represents ~50% of all design starts; long-term data center share expected to be 25–35% of total business.
  • FlexGen has higher ASP and royalty per chip; most FlexGen deals started mid-2025, used in server/FPGA (lower volume) and automotive (higher volume but 2030–2031 royalty lag).
  • Half of total royalties come from automotive; automotive FlexGen designs today would yield royalties only by 2030–2031.
• Mgmt stance: Neutral-to-bullish on data center pivot; cautious on FlexGen royalty timing due to long product cycles (automotive).